Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Prochlorperazine tablets repackaged into dose administration aids: can the patient be assured of quality
Journal of Clinical Pharmacy and Therapeutics, 12/10/08
Glass B et al. - Despite the confirmation of physical and chemical stability within BP limits, the discoloration and the potential for photodegradants to cause adverse effects in patients must lead us to draw the conclusion that the quality of this medication has been compromised. Pharmacists thus need to take this into account in repackaging and storage of prochlorperazine in DAAs and advise patients to store their DAA protected from light, heat and humidity.
Related Articles
Intraoperative Epidural Catheter Migration Into Subarachnoid Space Leading To Massive Subarachnoid Injection Of Morpine
Middle East Journal of Anesthesiology, 10/26/09
Relevance Score: 80%
Take multiple factors into account when choosing the best opioid for pain therapy in paediatric palliative care
Drugs & Therapy Perspectives, 10/16/09
Relevance Score: 79%
Efficacy and long-term tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain
Current Medical Research and Opinion, 10/13/09
Relevance Score: 79%
What anesthesiologists should know about paracetamol (acetaminophen)
Minerva Anestesiologica, 11/04/09
Relevance Score: 77%
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: A randomised phase 2 trial
The Lancet, 11/05/09
Relevance Score: 68%
Today in Dosing...keeping you current
Receive free subspecialty "5-minute updates" via email
High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial
BMC Infectious Diseases, 12/03/09
Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: A double- blind, randomized, multicentre, placebo-controlled trial
Amyotrophic Lateral Sclerosis, 12/03/09
Ustekinumab (Stelara): First-in-class human monoclonal antibody approved for treatment of moderate-to-severe plaque psoriasis
Formulary , 12/02/09
Today in Patient Counseling...keeping you current
Receive free subspecialty "5-minute updates" via email
Vascular Access-Related Bloodstream Infections in First Nations, Community and Teaching Canadian Dialysis Units, and Other Centre-Level Predictors
Nephron: Clinical Practice, 12/03/09
Unexpected Occurrence of Xeroderma Pigmentosum in an Uncle and Nephew
Archives of Dermatology, 11/25/09
Male involvement in antenatal HIV counseling and testing: exploring mens perceptions in rural Malawi
AIDS Care, 11/23/09
Sponsor
Article Search
Sponsor


See Latest Articles


